Renovorx
Clinical trials sponsored by Renovorx, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New catheter method aims chemo directly at pancreatic tumors Results expected Jun 2027 (estimated)
-
New catheter method aims chemo directly at pancreatic tumors
Disease control Recruiting nowThis Phase 3 trial tests whether delivering chemotherapy directly into the artery feeding the tumor can help people with locally advanced pancreatic cancer live longer. Participants first get standard chemo and radiation, then are randomly assigned to either continue standard IV …
Phase 3 • Sponsor: RenovoRx • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New catheter study tracks targeted chemo delivery for solid tumors
Knowledge-focused Recruiting nowThis study is collecting information from 1,000 people with solid tumors who receive chemotherapy through a special catheter called RenovoCath, which delivers drugs directly to the tumor site. Researchers are tracking safety, side effects, and survival over time. The goal is to l…
Sponsor: RenovoRx • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC